MedEdge Holdings has named Craig Gaffin, former president of Smith+Nephew’s approximately $2 billion global orthopedics business, as partner, the Greenwich, Conn.-based surgical technology platform said in a July 16 news release shared with Becker’s.
Mr. Gaffin brings more than 25 years of medical technology commercial leadership to MedEdge, which is building a portfolio of surgical products companies while operating a nationwide network of more than 5,000 independent and direct sales representatives across multiple surgical specialties.
At Smith+Nephew, Mr. Gaffin led the global orthopaedics franchise after previously heading its global trauma and extremities business. Earlier roles included senior positions at Stryker, Amgen and NICO Corp.
As partner, Mr. Gaffin will evaluate acquisition targets, support portfolio company growth and help expand MedEdge’s commercial platform, according to the release.
“The next generation of surgical innovation won’t be defined solely by breakthrough technologies,” said John Pacifico, MedEdge founder and executive chairman. “It will be defined by how effectively those technologies reach surgeons and patients.”
MedEdge was founded in 2025 through the combination of the biosurgical products business of Abyrx and a commercialization platform developed by Kairuku. The company’s relationship with Mr. Gaffin dates to 2019, when Abyrx partnered with Smith+Nephew’s trauma business through a commercial agency agreement — a collaboration Mr. Pacifico said demonstrated the MedEdge model in practice.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.